FDA PRO Guidance and ePRO patient reported outcomes solutions with patient eDiaries

Contact Us | US 1.877.360.2901 | EUR 41.22.879.91.00

Follow Us On Twitter          

"PHT's ePRO solutions enable us to gain real insight into how patients are reacting to, and benefiting from, our innovative sublingual immunotherapy treatments for ragweed, dust mite, cat and timothy grass allergies."

Brad Whitlow
Clinical Project Manager Greer Laboratories

Read more on what people are saying about PHT.

Videos

3 Steps to Cost-effectively Incorporate PROs in Clinical Research

Interview with Sheila Rocchio, PHT VP Marketing & Product Management



Strategies to Break Through the 'Bamboo Ceiling'

Interview with Phil Lee, PHT President & CEO



2012 Major Trends in eClinical Research

Interview with Phil Lee, PHT President & CEO



Patient Non-compliance with Paper Diaries

Presented by PHT President & CEO, Philip Lee, November 2011 at the PRO & ePRO Congress Boston, MA

Top 10 Most Important Developments in the PRO/ePRO Industry
(Top 1-5)

Presented by PHT President & CEO, Philip Lee, November 2011 at the PRO & ePRO Congress Boston, MA



Top 10 Most Important Developments in the PRO/ePRO Industry
(Top 5-10)

Presented by PHT President & CEO, Philip Lee, November 2011 at the PRO & ePRO Congress Boston, MA



Contact Us Products & Solutions Experience PHT Why ePRO? Resources Company Sitemap Privacy Policy
® 2012 PHT Corporation